Clinical Trial Update: Prevention of Seasonal Affective Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for prevention of Seasonal affective disorder has completed; sponsor listed as GlaxoSmithKline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Affective Disorder

Snippet

Sponsor: GlaxoSmithKline | Conditions: Seasonal Affective Disorder (SAD) | Phase 3 | Status: COMPLETED